Restore Robotics Receives FDA 510(k) Clearance for Two Additional da Vinci Xi® Robotic Instruments
March 31, 2026
Restore Robotics today announced it has received additional 510(k) clearances from the U.S. Food and Drug Administration (FDA) for the remanufacturing of two more da Vinci Xi® robotic surgical instruments. This milestone expands Restore Robotics’ growing portfolio of cleared instruments and further strengthens its position as a leader in robotic instrument remanufacturing.
Robotic Instrument Sales and Remanufacturing
• Sales of Remanufactured Robotic Instruments
• Sales of Pre-Owned Robotic Instruments
• Recycling of expired Robotic Instruments
Our National Sales and Service Centers have been providing medical device sales and remanufacturing for many years.

